TABLE 3.
Control | Untreated MI | Lipoic acid | Zinc | Clopidogrel | |
(25) | (16) | (24) | (24) | (25) | |
Troponin I (ng/ml) | |||||
Median | 0.6250 | 0.8333a | 0.8542a | 0.8542a | 0.7292 |
25th percentile | 0.3333 | 0.5000 | 0.4479 | 0.5209 | 0.5313 |
75th percentile | 0.7500 | 1.4375 | 1.5935 | 1.07275 | 1.31275 |
CK-MB (mU/ml) | 280.12 ± 35.60 | 454.24 ± 61.62a | 255.33 ± 33.49b | 614.13 ± 77.56a | 216.53 ± 32.46b |
TG (mg/dl) | 123.25 ± 8.87 | 149.67 ± 13.61 | 77.07 ± 5.38ab | 150.73 ± 15.98 | 94.67 ± 6.99ab |
TC (mg/dl) | 78.52 ± 14.21 | 101.53 ± 7.35 | 73.40 ± 5.75b | 81.00 ± 4.80b | 92.73 ± 4.70 |
Values are represented as mean ± SEM (except for troponin I). The number of observations is given in parentheses. MI, myocardial infarction; CK-MB, creatine kinase-MB; TG, triglycerides; TC, total cholesterol. aSignificance of differences from control group calculated by the Mann–Whitney test in case of troponin I and Student’s t-test for unpaired data in case of CK-MB, TG and TC at p < 0.05. bSignificance of differences from MI group calculated by Student’s t-test for unpaired data at p < 0.05.